Caregivers
There is an increased risk of cancer in A-T carriers necessitating enhanced cancer surveillance.
A-T organizations around the world collaborate and look for a cure.
Physicians may consult a hematologist who is familiar with cancer and A-T.
The gene causing A-T (the ATM gene) was identified in 1995. This gene produces ATM protein.
A-T is inherited, or passed on, in families from parents to children.
The neurology of A-T is incredibly complicated and the neurologic impairments of A-T are many and varied.
Many, but not all, A-T patients have abnormalities of immune function.
This chapter provides basic information about some of the illnesses that your child may experience.
Feeding and swallowing problems become more common among people with A-T during the teenage years.
This chapter addresses the cancer risk faced by people with A-T and provides guidelines for x-ray exposure.